Cargando…

Atypical Presentation of Primary Cutaneous CD8 Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma

Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma (PCAT) is a rare and heterogeneous entity with less than 100 published cases to date. A 68-year-old man was following up for an inflammatory lichen–lupus overlap dermatosis of 3 years duration. Treatment with methotre...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez, Aitana R., Sambucety, Pedro S., García, Camino P., Prieto, Manuel A. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536060/
https://www.ncbi.nlm.nih.gov/pubmed/31149576
http://dx.doi.org/10.4103/idoj.IDOJ_257_18
_version_ 1783421691412611072
author Sánchez, Aitana R.
Sambucety, Pedro S.
García, Camino P.
Prieto, Manuel A. R.
author_facet Sánchez, Aitana R.
Sambucety, Pedro S.
García, Camino P.
Prieto, Manuel A. R.
author_sort Sánchez, Aitana R.
collection PubMed
description Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma (PCAT) is a rare and heterogeneous entity with less than 100 published cases to date. A 68-year-old man was following up for an inflammatory lichen–lupus overlap dermatosis of 3 years duration. Treatment with methotrexate was started, observing a dramatic change in the skin lesions that became infiltrated plaques and generalized ulcerated tumours distributed over trunk and extremities. Histological study showed marked epidermotropism of CD8 positive cells and monoclonality was demonstrated by the polymerase chain reaction. Diagnosis of PCAT was concluded. Treatment with polychemotherapy was indicated. The PCAT is characterized by a rapid clinical history of generalized papules, plaques, nodules and tumours with frequent ulceration and necrosis. Although it has no pathognomonic clinical features, there are clinical, histological and prognostic data that define them as a group and differentiate them from other lymphomas. Exceptionally, there are cases reported which have been triggered following treatment with immunosuppressive drugs. In our patient we think that PCAT was triggered by the transformation of a pre-existing dermatosis, which had never showed a lymphoproliferative profile in biopsies before. A possible pathogenic mechanism is that in some inflammatory dermatoses, chronic antigenic stimulation in a situation of iatrogenic immunosuppression may favour the development of a malignant clonal T cell.
format Online
Article
Text
id pubmed-6536060
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-65360602019-05-30 Atypical Presentation of Primary Cutaneous CD8 Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma Sánchez, Aitana R. Sambucety, Pedro S. García, Camino P. Prieto, Manuel A. R. Indian Dermatol Online J Case Report Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma (PCAT) is a rare and heterogeneous entity with less than 100 published cases to date. A 68-year-old man was following up for an inflammatory lichen–lupus overlap dermatosis of 3 years duration. Treatment with methotrexate was started, observing a dramatic change in the skin lesions that became infiltrated plaques and generalized ulcerated tumours distributed over trunk and extremities. Histological study showed marked epidermotropism of CD8 positive cells and monoclonality was demonstrated by the polymerase chain reaction. Diagnosis of PCAT was concluded. Treatment with polychemotherapy was indicated. The PCAT is characterized by a rapid clinical history of generalized papules, plaques, nodules and tumours with frequent ulceration and necrosis. Although it has no pathognomonic clinical features, there are clinical, histological and prognostic data that define them as a group and differentiate them from other lymphomas. Exceptionally, there are cases reported which have been triggered following treatment with immunosuppressive drugs. In our patient we think that PCAT was triggered by the transformation of a pre-existing dermatosis, which had never showed a lymphoproliferative profile in biopsies before. A possible pathogenic mechanism is that in some inflammatory dermatoses, chronic antigenic stimulation in a situation of iatrogenic immunosuppression may favour the development of a malignant clonal T cell. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6536060/ /pubmed/31149576 http://dx.doi.org/10.4103/idoj.IDOJ_257_18 Text en Copyright: © 2019 Indian Dermatology Online Journal http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Report
Sánchez, Aitana R.
Sambucety, Pedro S.
García, Camino P.
Prieto, Manuel A. R.
Atypical Presentation of Primary Cutaneous CD8 Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma
title Atypical Presentation of Primary Cutaneous CD8 Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma
title_full Atypical Presentation of Primary Cutaneous CD8 Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma
title_fullStr Atypical Presentation of Primary Cutaneous CD8 Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma
title_full_unstemmed Atypical Presentation of Primary Cutaneous CD8 Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma
title_short Atypical Presentation of Primary Cutaneous CD8 Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma
title_sort atypical presentation of primary cutaneous cd8 positive aggressive epidermotropic cytotoxic t-cell lymphoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536060/
https://www.ncbi.nlm.nih.gov/pubmed/31149576
http://dx.doi.org/10.4103/idoj.IDOJ_257_18
work_keys_str_mv AT sanchezaitanar atypicalpresentationofprimarycutaneouscd8positiveaggressiveepidermotropiccytotoxictcelllymphoma
AT sambucetypedros atypicalpresentationofprimarycutaneouscd8positiveaggressiveepidermotropiccytotoxictcelllymphoma
AT garciacaminop atypicalpresentationofprimarycutaneouscd8positiveaggressiveepidermotropiccytotoxictcelllymphoma
AT prietomanuelar atypicalpresentationofprimarycutaneouscd8positiveaggressiveepidermotropiccytotoxictcelllymphoma